Package Leaflet: Information for the User
Diltix 400 mg Film-Coated TabletsEFG
Ibuprofen
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Follow the administration instructions for the medication contained in this package leaflet or as indicated by your doctor or pharmacist exactly.
Package Leaflet Contents
Diltix contains the active ingredient ibuprofen. Ibuprofen is a medication that reduces fever and relieves pain (non-steroidal anti-inflammatory medication (NSAID)).
In adults and adolescents weighing 40 kg or more (12 years or older), it is used for the short-term symptomatic treatment of mild or moderate pain and/or fever.
Do not take Diltix if
Warnings and Precautions
Adverse reactions are minimized by using the lowest effective dose for the shortest possible time.
You should consult your treatment with your doctor or pharmacist before taking ibuprofen if:
Effects on the Gastrointestinal Tract
The use of ibuprofen in combination with other non-steroidal anti-inflammatory medications (NSAIDs), including so-called COX-2 inhibitors (inhibitors of cyclooxygenase-2), should be avoided.
Gastrointestinal Tract Bleeding, Ulcers, and Perforation
Cases of gastrointestinal tract bleeding, ulcers, and perforation (which can be fatal) have been reported during treatment with NSAIDs. At any time during treatment, with or without previous warning symptoms, and with or without a history of previous serious gastrointestinal events.
The risk of experiencing gastrointestinal bleeding, ulcers, and perforation is greater with increased NSAID doses and is greater in patients with a history of ulcers, especially with complications of bleeding or perforation (see section 2 "Do not take Diltix") and in elderly patients. These patients should start treatment with the lowest available dose.
For these patients, as well as for patients who require additional treatment with low doses of acetylsalicylic acid or other medications that may increase the risk of gastrointestinal disorders, your doctor will consider the possibility of associating a stomach-protecting medication (e.g., misoprostol or proton pump inhibitors).
If you have a history of adverse reactions that affect the gastrointestinal tract - especially in elderly patients - consult your doctor in case of unusual abdominal symptoms (especially gastrointestinal bleeding), particularly at the start of therapy.
Caution is recommended if you are also taking other medications that may increase the risk of ulcers or bleeding, such as oral corticosteroids, anticoagulants (e.g., warfarin), selective serotonin reuptake inhibitors (used to treat psychiatric disorders, including depression), or platelet aggregation inhibitors like acetylsalicylic acid (see section 2 "Other Medications and Diltix").
You should discontinue treatment and consult a doctor if you develop gastrointestinal bleeding or ulcers during treatment with ibuprofen.
Effects on the Cardiovascular System
Anti-inflammatory/analgesic medications like ibuprofen may be associated with a small increased risk of suffering a heart attack or stroke, especially when used in high doses. Do not exceed the recommended dose or treatment duration.
You should discuss your treatment with your doctor or pharmacist before taking ibuprofen if:
Signs of an allergic reaction to this medication, including breathing problems, facial and neck swelling (angioedema), and chest pain, have been reported with ibuprofen. Discontinue treatment with ibuprofen immediately and contact your doctor as soon as possible if you notice any of these signs.
Skin Reactions
Severe skin reactions, including exfoliative dermatitis, multiforme exanthema, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalized exanthematous pustulosis (AGEP), have been reported in relation to ibuprofen treatment. Stop taking ibuprofeno and seek immediate medical attention if you notice any symptoms related to these severe skin reactions described in section 4.
If you have chickenpox, it is advisable to avoid using ibuprofen.
Infections
Ibuprofen may mask the signs of an infection, such as fever and pain. Consequently, it is possible that ibuprofen may delay appropriate treatment of the infection, which may increase the risk of complications. This has been observed in bacterial pneumonia and bacterial skin infections related to chickenpox. If you take this medication while having an infection and the symptoms of the infection persist or worsen, consult a doctor without delay.
Other Warnings
In very rare cases, severe acute hypersensitivity reactions (e.g., anaphylactic shock) have been observed. At the first signs of a hypersensitivity reaction after taking ibuprofen, treatment should be discontinued and a doctor consulted. Medically required measures, in line with the symptoms, should be initiated by specialized personnel.
Ibuprofen may reversibly inhibit platelet aggregation and function (platelet aggregation). Therefore, patients with coagulation disorders should be carefully monitored.
During prolonged use of ibuprofen, regular monitoring of liver function tests, kidney function, and blood counts is required.
Prolonged use of any type of analgesic for headache may worsen it. If this situation is observed or suspected, consult a doctor and discontinue treatment.
In general, habitual use of different types of analgesics can lead to the appearance of serious kidney problems with a risk of renal failure (analgesic nephropathy). This risk can be increased in conditions of physical exertion associated with loss of salts and dehydration. Therefore, it should be avoided.
The risk of renal failure increases in dehydrated patients, elderly patients, and those taking diuretics and ACE inhibitors.
In case of vision problems, please consult your doctor.
Elderly Patients
Elderly patients have a higher frequency of adverse reactions to NSAIDs (non-steroidal anti-inflammatory drugs), especially gastrointestinal bleeding and perforation, which can be fatal (see also the warning about bleeding at the beginning of section 2).
Adolescents
There is a risk of renal failure in dehydrated adolescents.
Other Medications and Diltix
Inform your doctor or pharmacist that you are using or have recently used or may need to use any other medication.
Ibuprofen may affect or be affected by other medications. For example:
Other medications may also affect or be affected by treatment with ibuprofen. Therefore, you should always consult your doctor or pharmacist before using ibuprofen with other medications.
Taking Diltix with Alcohol
The adverse reactions of ibuprofen may be increased with the consumption of alcohol, especially those affecting the central nervous system and the gastrointestinal tract. You should not drink alcohol while taking ibuprofen.
Pregnancy, Breastfeeding, and Fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Pregnancy
Do not take ibuprofen if you are in the last 3 months of pregnancy, as it may harm the fetus or cause problems during delivery. It may cause kidney and heart problems in your fetus. It may affect your and your baby's tendency to bleed and delay or prolong delivery more than expected. You should not take ibuprofen during the first 6 months of pregnancy unless it is clearly necessary and as indicated by your doctor. If you need treatment during this period or while trying to become pregnant, you should take the minimum dose for the shortest possible time. From the 20th week of pregnancy, ibuprofen may cause kidney problems in your fetus if taken for more than a few days, which may cause low levels of the fluid surrounding the baby (oligohydramnios) or narrowing of a blood vessel (ductus arteriosus) in the baby's heart. If you need treatment for more than a few days, your doctor may recommend additional monitoring.
Breastfeeding
Small amounts of ibuprofen pass into breast milk. However, as no harmful effects have been reported in children to date, it is not usually necessary to interrupt breastfeeding during short-term use of ibuprofen at the recommended dose for fever and pain.
Fertility
This product belongs to the group of NSAIDs that may affect fertility in women. This effect is reversible upon discontinuation of the medication. You should consult your doctor if you plan to become pregnant or if you have difficulty becoming pregnant.
Driving and Using Machines
Ibuprofen generally has a negligible influence on the ability to drive and use machines. However, at higher doses, adverse effects such as fatigue and dizziness may occur, and reaction capacity may be affected while driving and operating machines. This is especially important when the medication is combined with alcohol.
Diltix Contains Lactose
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Diltix Contains Sodium
This medication contains less than 23 mg of sodium (1 mmol) per tablet; it is essentially "sodium-free".
Follow the administration instructions for this medication exactly as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The lowest effective dose should be used for the shortest time necessary to relieve symptoms. If you have an infection, consult a doctor without delay if symptoms (such as fever and pain) persist or worsen (see section 2). The recommended dose is:
Adults and adolescents from 40 kg in weight (from 12 years or older)
Half a tablet (200 mg) or one whole tablet (400 mg) as a single dose. If necessary, take an additional half or one tablet.
The dosing interval should be chosen according to the observed symptoms and the recommended maximum daily dose. The interval between doses should not be less than 6 hours. Do not take more than 3 tablets (1200 mg) of ibuprofen in a 24-hour period.
Ibuprofen 400 mg is not recommended for use in adolescents with less than 40 kg in weight or children under 12 years of age.
Adverse reactions can be minimized by using the lowest effective dose for the shortest time possible to control symptoms.
If you have severe liver or kidney disease or are an elderly patient, your doctor will indicate the correct dose for you to take, which will be the lowest possible dose.
Method of administration
Oral.
Take the tablet with a glass of water.
Ibuprofen tablets should not be crushed, chewed, or sucked to avoid discomfort in the mouth or throat irritation. The tablets can be divided into equal doses.
It is recommended that patients with sensitive stomachs take ibuprofen with food.
Ibuprofen is intended for short-term use only.
For adults
If you need this medication for more than 3 days to treat fever or for more than 4 days to treat pain, or if symptoms worsen, you should consult a doctor.
For adolescents
If adolescents need this medication for more than 3 days, or if symptoms worsen, they should consult a doctor.
If you take more Diltix than you should
If you have taken more ibuprofen than you should, or if a child has accidentally ingested the medication, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested, or go to the nearest hospital to find out about the risk and ask for advice on the measures to be taken.
Symptoms of overdose may include nausea, stomach pain, vomiting (which may contain bloody sputum), and rarely diarrhea. Additionally, it may cause headache, gastrointestinal bleeding, blurred vision, ringing in the ears, confusion, involuntary eye movement, and worsening of asthma in asthmatics. At high doses, symptoms of drowsiness, excitement, disorientation, chest pain, palpitations, loss of consciousness, coma, convulsions (mainly in children), dizziness, weakness, and dizziness, blood in the urine, low potassium levels in the blood, low blood pressure, high potassium levels in the blood, increased prothrombin time/INR, acute renal failure, liver damage, respiratory depression, cyanosis, decreased body temperature, and respiratory problems have been reported.
If you forget to take Diltix
Do not take a double dose to make up for forgotten doses.
If you have any further questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone will experience them.
The most common side effects observed affect the digestive tract. Stomach/duodenal ulcers (peptic ulcers), perforation, or bleeding may occur, sometimes fatally, especially in elderly patients (see section 2: "Warnings and precautions"). Nausea, vomiting, diarrhea, flatulence, constipation, digestive problems, abdominal pain, blood in stool, vomiting with blood, sores (ulcers) in the mouth and throat area (stomatitis ulcerosa), exacerbation of colitis and Crohn's disease (see section 2: "Warnings and precautions") have been reported after its use. Gastritis has been observed less frequently. In particular, the risk of developing gastrointestinal bleeding depends on the dose level and treatment duration.
Inflammation (edema), high blood pressure (hypertension), and heart failure have been observed in association with NSAID treatments.
More serious side effects
If you experience any of these side effects or if they worsen, stop treatment and go to your doctor immediately.
Other side effects
Frequent (may affect more than 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Stop taking ibuprofen and inform your doctor immediately.
Rare (may affect up to 1 in 1,000 people)
Very rare (may affect up to 1 in 10,000 people)
Frequency not known (cannot be estimated from available data)
Medications like ibuprofen may be associated with a small increased risk of suffering a heart attack ("myocardial infarction") or stroke.
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Medicines Monitoring System for Human Use: www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date shown on the box after CAD. The expiration date is the last day of the month indicated.
Do not store above 25°C.
Medications should not be disposed of through wastewater or household waste. Deposit the containers and medications you no longer need at the SIGRE collection point in the pharmacy. Ask your pharmacist how to dispose of the containers and medications you no longer need. This will help protect the environment.
Diltix composition
The active ingredient is ibuprofen. Each tablet contains 400 mg of ibuprofen.
The other ingredients are:
Tablet core:hypromellose, sodium croscarmellose, lactose monohydrate, microcrystalline cellulose, pregelatinized corn starch, anhydrous colloidal silica, sodium lauryl sulfate, magnesium stearate.
Coating:hypromellose, titanium dioxide (E-171), talc, and propylene glycol.
Product appearance and package contents
White or off-white, round, scored, film-coated tablets with a diameter of approximately 12 mm.
The tablet can be divided into equal doses.
They are available in blister packs of 10, 12, 20, 24, 30, 50, or 60 film-coated tablets.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Aristo Pharma GmbH
Wallenroder Strasse 8-10,
Berlin - 13435 - Germany
You can request more information about this medication by contacting the local representative of the marketing authorization holder:
Aristo Pharma Iberia, S.L.
C/ Solana, 26
28850, Torrejón de Ardoz
Madrid, Spain
This medication is authorized in the Member States of the European Economic Area under the following names:
Germany: IbuARISTO akut 400 mg
Italy: Ibuprofene Aristo
Poland: Axoprofen Forte
Spain: Diltix 400 mg film-coated tablets EFG
Date of the last revision of this leaflet:09/2024
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/